Regeneron to share technology with Texas researchers
-
- April
- 1
Regeneron Pharmaceuticals Inc., a biotech company in Eastview, announced an agreement to share key technology with researchers at the University of Texas Southwestern Medical Center in Dallas. Regeneron said the technology, known as VelocImmune, increases the speed of human antibody development. Under the agreement, the university’s researchers can use the technology to help develop new medications.
This entry was posted
on Wednesday, April 1st, 2009 at 1:43 pm by Jay Loomis.
You can follow any responses to this entry through the RSS 2.0 feed.
Print
|
Email
Leave a Reply
It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the
Terms of Service.